Literature DB >> 7749794

Cryptococcal pneumonia in AIDS: is cryptococcal meningitis preceded by clinically recognizable pneumonia?

J A Driver1, C A Saunders, B Heinze-Lacey, A M Sugar.   

Abstract

Identification of cryptococcal infection while it is still in its pulmonary phase might improve the prognosis for patients with AIDS who contract cryptococcosis. Since cryptococcal pneumonia is infrequently diagnosed in the AIDS patient, especially compared with the frequency of diagnosis of cryptococcal meningitis, this retrospective study was designed to investigate the frequency of pulmonary complaints in the months before diagnosis of cryptococcal meningitis. The medical records of 18 patients diagnosed with cryptococcal meningitis were analyzed. Of 18 patients, 14 (78%) had respiratory symptoms during the 4-month period before meningitis appeared, as compared with nine of 18 (50%) at the time of diagnosis and four of 16 (25%) in the 4 months following diagnosis. Seven of the 14 cases of pulmonary disease prediagnosis were of unknown etiology; three were eventually diagnosed as cryptococcal infections during evaluation of the meningitis. The remaining eight infections were attributed to bacteria, respiratory viruses, or Pneumocystis carinii, although three of these cultures also contained yeast, presumed to be Candida species, which were not further examined. Our data suggest the importance of singling out AIDS patients who may have pulmonary cryptococcosis. Cryptocococcsis should be included in the differential diagnosis of pulmonary infection in HIV-positive patients with CD4+ lymphocyte counts < 200/mm3, and full identification of yeasts recovered from sputum or bronchoalveolar lavage fluid cultures should be done. A larger study should be undertaken to better define the incidence of clinically recognizable pulmonary cryptococcosis in AIDS patients.

Entities:  

Mesh:

Year:  1995        PMID: 7749794

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  14 in total

1.  Pyrexia of undetermined origin in the era of HAART.

Authors:  W Whitely; A Tariq; B Peters; G Kocjan; R F Miller
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

2.  Cryptococcal Meningitis in HIV-Infected Patients.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

3.  Utility of routine testing of bronchoalveolar lavage fluid for cryptococcal antigen.

Authors:  S M Kralovic; J C Rhodes
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  The invasive behaviour of Cryptococcus neoformans: a possibility of direct access to the central nervous system?

Authors:  N G Gomes; M Boni; C C Primo
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

5.  Cryptococcal-related Mortality Despite Fluconazole Preemptive Treatment in a Cryptococcal Antigen Screen-and-Treat Program.

Authors:  Rachel M Wake; Nelesh P Govender; Tanvier Omar; Carolina Nel; Ahmad Haeri Mazanderani; Aaron S Karat; Nazir A Ismail; Caroline T Tiemessen; Joseph N Jarvis; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

6.  A murine model of Cryptococcus gattii meningoencephalitis.

Authors:  George R Thompson; Nathan P Wiederhold; Laura K Najvar; Rosie Bocanegra; William R Kirkpatrick; John R Graybill; Thomas F Patterson
Journal:  J Antimicrob Chemother       Date:  2012-02-29       Impact factor: 5.790

Review 7.  Dueling in the lung: how Cryptococcus spores race the host for survival.

Authors:  Michael R Botts; Christina M Hull
Journal:  Curr Opin Microbiol       Date:  2010-08       Impact factor: 7.934

8.  Isolation and characterization of Cryptococcus neoformans spores reveal a critical role for capsule biosynthesis genes in spore biogenesis.

Authors:  Michael R Botts; Steven S Giles; Marcellene A Gates; Thomas R Kozel; Christina M Hull
Journal:  Eukaryot Cell       Date:  2009-01-30

9.  CrAg lateral flow assay for cryptococcosis.

Authors:  Thomas R Kozel; Sean K Bauman
Journal:  Expert Opin Med Diagn       Date:  2012-04-19

10.  Leveraging a high resolution microfluidic assay reveals insights into pathogenic fungal spore germination.

Authors:  Layla J Barkal; Naomi M Walsh; Michael R Botts; David J Beebe; Christina M Hull
Journal:  Integr Biol (Camb)       Date:  2016-03-30       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.